Exane Derivatives’s AngloGold Ashanti AU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,425
Closed -$249K 830
2020
Q3
$249K Buy
9,425
+9,400
+37,600% +$281K 0.07% 193
2020
Q2
$737 Sell
25
-466
-95% -$11.5K ﹤0.01% 579
2020
Q1
$8.16K Sell
491
-12,955
-96% -$254K ﹤0.01% 430
2019
Q4
$280K Buy
13,446
+992
+8% +$20K 0.05% 214
2019
Q3
$228K Buy
12,454
+8,731
+235% +$173K 0.04% 231
2019
Q2
$66.3K Buy
+3,723
New +$50K 0.01% 366
2018
Q3
Sell
-163,713
Closed -$1.34M 695
2018
Q2
$1.34M Buy
163,713
+134,492
+460% +$1.18M 0.22% 93
2018
Q1
$277K Sell
29,221
-48,445
-62% -$494K 0.06% 218
2017
Q4
$791K Sell
77,666
-68,088
-47% -$656K 0.14% 124
2017
Q3
$1.35M Buy
145,754
+102,336
+236% +$990K 0.25% 73
2017
Q2
$422K Buy
+43,418
New +$495K 0.09% 146

Other funds holding AU

Exane Derivatives's AU Position: Q4 2020 in Review

Exane Derivatives sold out of AngloGold Ashanti (AU) in Q4 2020, closing a stake of 9,425 shares — an estimated $249K sold.

Exane Derivatives first reported a position in AU in Q2 2017 and held it in 11 quarters. The position peaked at $1.35M in Q3 2017. 190 funds tracked by Wall St. Rank hold AU as of Q4 2020.

  • Exane Derivatives reported no remaining AngloGold Ashanti position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 9,425 AngloGold Ashanti shares in Q4 2020, an estimated $249K.
  • Exane Derivatives first reported a position in AngloGold Ashanti in Q2 2017 and held it in 11 quarters.
  • Exane Derivatives's AngloGold Ashanti position peaked at $1.35M in Q3 2017.
  • 190 funds tracked by Wall St. Rank held AngloGold Ashanti as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.